Q5T7S2 (Q5T7S2_HUMAN) Homo sapiens (Human)

TGF-beta receptor type-1 UniProtKBInterProInteractive Modelling

503 aa; Sequence (Fasta) ; 1 identical sequence: Homo sapiens: P36897

Available Structures

40 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF THE TYPE I TGF-BETA RECEPTOR IN COMPLEX WITH FKBP12 Heteromer
P36897; P62942;
175-500
100SO4;
Ternary structure of GDF11 bound to ActRIIB-ECD and Alk5-ECD Heteromer
O95390; P36897; P38445;
33-112
100NAG;
Structural basis for cooperative assembly of the TGF-beta signaling complex Heteromer
P10600; P36897; P37173;
33-111
98.73
Ternary complex of TGF-b1 reveals isoform-specific ligand recognition and receptor recruitment in t… Heteromer
P01137; P36897; P37173;
33-109
100.0
CYTOPLASMIC DOMAIN OF UNPHOSPHORYLATED TYPE I TGF-BETA RECEPTOR CRYSTALLIZED WITHOUT FKBP12homo-5-mer171-501
10015×SO4;
Crystal structure of TGFbRI complexed with a pyrazolone inhibitormonomer171-500
100.0JZO;PO4;
Crystal structure of TGFbRI complexed with a 2-aminoimidazole inhibitormonomer171-500
100.055F;PO4;
Crystal structure of TGFbRI complexed with an indolinone inhibitormonomer171-500
100ZOP;
TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D,I211V,Y249F,S280T, Y282F,S287N,A350C,L352F) IN COMPLE…monomer200-503
97.37STU;GOL;
TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D) IN COMPLEX WITH N-(3-fluoropyridin-4-yl)-2-[6-(trifl…monomer200-502
99.67D0A;
TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D) IN COMPLEX WITH 6-[4-(3-CHLORO-4-FLUOROPHENYL)-1-(2-…monomer200-502
99.67QMV;GOL;
Crystal Structure of a Naphthyridine Inhibitor of Human TGF-beta Type I Receptormonomer201-503
100.0460;
TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D,I211V,Y249F,S280T, Y282F,S287N,A350C,L352F)monomer200-502
97.36GOL;
The Crystal Structure of Tgf-Beta Type I Receptor (Alk5) from Biortusmonomer200-501
100A1D6I;EDO;ACY;
Selection of fragments for kinase inhibitor design: decoration is keymonomer200-501
1003WJ;SO4;
Selection of fragments for kinase inhibitor design: decoration is keymonomer200-501
1003WK;SO4;TRS;
Selection of fragments for kinase inhibitor design: decoration is keymonomer200-501
1003WA;SO4;
Selection of fragments for kinase inhibitor design: decoration is keymonomer200-501
1003WN;SO4;
Selection of fragments for kinase inhibitor design: decoration is keymonomer200-501
1003WO;SO4;
TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D) IN COMPLEX WITH N-{4-[3-(5-METHOXYPYRIDIN-2-YL)-1H-P…monomer200-501
100J2Y;GOL;
Selection of fragments for kinase inhibitor design: decoration is keymonomer200-501
100SO4;
TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D) IN COMPLEX WITH STAUROSPORINEmonomer200-501
99.67STU;GOL;
ALK5 IN COMPLEX WITH 4-((5,6-dimethyl-2-(2-pyridyl)-3-pyridyl)oxy)-N-(3,4,5-trimethoxyphenyl)pyridi…monomer200-500
100ZZG;EDO;
Crystal Structure of TGF-beta receptor I kinase with inhibitormonomer200-500
100SO4;PY1;
Crystal Structure of TGF-beta receptor I kinase with ATP site inhibitormonomer200-500
100580;
TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D) IN COMPLEX WITH 3-AMINO-6-[4-(2-HYDROXYETHYL)PHENYL]…monomer200-499
99.675L4;
TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D) IN COMPLEX WITH N-{4-[3-(6-fluoropyridin-3-yl)-4-oxo…monomer200-499
99.67J2M;GOL;
TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D)monomer200-499
99.67GOL;
TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D) IN COMPLEX WITH 6-[1-(2,2-DIFLUOROETHYL)-4-(6-METHYL…monomer200-499
99.67QMY;GOL;
TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D) IN COMPLEX WITH N-{4-[3-(6-METHOXYPYRIDIN-3-YL)-1H-P…monomer200-499
99.67J2V;
TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D,I211V,Y249F, S280T,Y282F,S287N,A350C,L352F) IN COMPLE…monomer200-499
97.335L4;
TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (WT)monomer200-498
100
ALK5 in complex witha an N-(4-anilino-2-pyridyl)acetamide inhibitor.monomer200-498
100EDO;ZUQ;
ALK-5 kinase inhibitor complexmonomer200-498
1008LY;
The Crystal Structure of the Type I TGF beta receptor from Biortus.monomer201-498
100A1D6I;
Structure of Alk5 + GW855857monomer201-498
100.0855;
ALK-5 kinase complex with GW857175monomer201-498
100.0QIG;
TGF-beta Receptor type 1 in complex with SB431542monomer200-496
100.0085;
ALK5 IN COMPLEX WITH 4-((4-((2,6-dimethyl-3-pyridyl)oxy)-2-pyridyl) amino)benzenesulfonamidemonomer200-496
100EDO;ZZF;
Solution structure of the extracellular domain of the TGF-beta type I receptormonomer31-115
100

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
2x7o.3.Amonomer0.79171-500
ZOP;100.00